BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 28752709)

  • 1. [ENTPD5 gene is highly expressed in epithelial ovarian cancer: analysis based on Oncomine database and bioinformatics].
    Wang H; Chen X; Chen Y; Cao Y; Chen Y; Liu G; Huang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):555-561. PubMed ID: 33963715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and analysis of multiple biomarkers in ovarian cancer: clinical significance in diagnosis, treatment, and prognosis evaluation.
    Ji R; Li Y; He C; Zhu X; He A; Lu Y
    Gland Surg; 2020 Dec; 9(6):2175-2186. PubMed ID: 33447568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High BMP7 expression is associated with poor prognosis in ovarian cancer.
    Vasan R; Yadav J; Aiyappa-Maudsley R; Deen S; Storr SJ; Martin SG
    J Cell Mol Med; 2023 Nov; 27(21):3378-3387. PubMed ID: 37688374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of INPP4B is Associated with Poor Prognosis in Epithelial Ovarian Carcinoma.
    Jiang L; Wang J
    Int J Gen Med; 2024; 17():1059-1072. PubMed ID: 38525069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Higher Expression of Talin-1 and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients.
    Sharbatoghli M; Saeednejad Zanjani L; Fahimeh F; Kalantari E; Habibi Shams Z; Panahi M; Totonchi M; Asadi-Lari M; Madjd Z
    Iran J Pathol; 2023; 18(3):312-326. PubMed ID: 37942198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uromodulin processing in DNAJB11-kidney disease.
    Mariniello M; Schiano G; Yoshifuji A; Gillion V; Sayer JA; Jouret F; ; Le Meur Y; Cornec-Le Gall E; Olinger EG; Devuyst O
    Kidney Int; 2024 Feb; 105(2):376-380. PubMed ID: 38016513
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma.
    Brunetti M; Holth A; Panagopoulos I; Staff AC; Micci F; Davidson B
    Virchows Arch; 2019 Feb; 474(2):177-185. PubMed ID: 30467600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of DNAJB11 in epithelial ovarian cancer].
    Guorong Y; Yunfeng FU; Yanli LI; Caiyun Z; Weiguo LV
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 46(2):173-178. PubMed ID: 28752709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
    BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
    Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
    J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 13. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.